MK-0653H
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-0653H, covering 2018-03-09 to 2018-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) [Phase 3]